BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lonardo A, Nascimbeni F, Maurantonio M, Marrazzo A, Rinaldi L, Adinolfi LE. Nonalcoholic fatty liver disease: Evolving paradigms. World J Gastroenterol 2017; 23(36): 6571-6592 [PMID: 29085206 DOI: 10.3748/wjg.v23.i36.6571]
URL: https://www.wjgnet.com/1007-9327/full/v23/i36/6571.htm
Number Citing Articles
1
Xuefeng Ma, Shousheng Liu, Jie Zhang, Mengzhen Dong, Yifen Wang, Mengke Wang, Yongning Xin. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysisBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1165-z
2
Guotai Sheng, Qiyang Xie, Rongsheng Wang, Chong Hu, Mingchun Zhong, Yang Zou. Waist-to-height ratio and non-alcoholic fatty liver disease in adultsBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01824-3
3
M.N. Mamedov, A.K. Karimov. Secondary hyperlipidemia: features of manifestation in various somatic diseasesProfilakticheskaya meditsina 2021; 24(3): 105 doi: 10.17116/profmed202124031105
4
Yun Xu, Yongfang Jiang, Yi Li. Pyrazinamide enhances lipid peroxidation and antioxidant levels to induce liver injury in rat models through PI3k/Akt inhibitionToxicology Research 2020; 9(3): 149 doi: 10.1093/toxres/tfaa015
5
Rosa Zampino, Aldo Marrone, Luca Rinaldi, Barbara Guerrera, Riccardo Nevola, Adriana Boemio, Natalina Iuliano, Mauro Giordano, Nicola Passariello, Ferdinando C. Sasso, Emanuele Albano, Luigi E. Adinolfi. Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stressInfection 2018; 46(6): 793 doi: 10.1007/s15010-018-1185-6
6
Alfredo Caturano, Carlo Acierno, Riccardo Nevola, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Teresa Salvatore, Luigi Elio Adinolfi, Ferdinando Carlo Sasso. Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical ImpactProcesses 2021; 9(1): 135 doi: 10.3390/pr9010135
7
Toshihiro Umehara, Giovanni Targher. Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adultsPLOS ONE 2018; 13(6): e0197900 doi: 10.1371/journal.pone.0197900
8
Rajvi Gor, Nabeel A Siddiqui, Ransirini Wijeratne Fernando, Archana Sreekantan Nair, Janan Illango, Mushrin Malik, Pousette Hamid. Unraveling the Role of Hypothyroidism in Non-alcoholic Fatty Liver Disease Pathogenesis: Correlations, Conflicts, and the Current StandCureus 2021;  doi: 10.7759/cureus.14858
9
Jorge Magdaleno‐Tapial, Cristian Valenzuela‐Oñate, José María Ortiz‐Salvador, Álvaro Martínez‐Doménech, Marta García‐Legaz‐Martínez, Miriam Alonso‐Carpio, Juan José Tamarit‐García, Moisés Diago‐Madrid, José Luis Sánchez‐Carazo, Amparo Pérez‐Ferriols. Prevalence of non‐alcoholic fatty liver and liver fibrosis in patients with moderate–severe psoriasis: A cross‐sectional cohort studyAustralasian Journal of Dermatology 2020; 61(2): 105 doi: 10.1111/ajd.13175
10
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesityAnnals of Hepatology 2020; 19(4): 359 doi: 10.1016/j.aohep.2020.03.001
11
Mayra Domínguez‐Pérez, Arturo Simoni‐Nieves, Patricia Rosales, Natalia Nuño‐Lámbarri, Mónica Rosas‐Lemus, Verónica Souza, Roxana U. Miranda, Leticia Bucio, Salvador Uribe Carvajal, Jens U. Marquardt, Daekwan Seo, Luis E. Gomez‐Quiroz, María Concepción Gutiérrez‐Ruiz. Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosisJournal of Cellular Physiology 2019; 234(5): 7213 doi: 10.1002/jcp.27474
12
Jinxiu Li, Shang Wang, Ling Yao, Peng Ma, Zhiwei Chen, Ting-Li Han, Chunlin Yuan, Jun Zhang, Lirong Jiang, Li Liu, Dazhi Ke, Chunli Li, Johji Yamahara, Yuhao Li, Jianwei Wang. 6-gingerol ameliorates age-related hepatic steatosis: Association with regulating lipogenesis, fatty acid oxidation, oxidative stress and mitochondrial dysfunctionToxicology and Applied Pharmacology 2019; 362: 125 doi: 10.1016/j.taap.2018.11.001
13
Luca Rinaldi, Maria Guarino, Alessandro Perrella, Pia Clara Pafundi, Giovanna Valente, Luca Fontanella, Riccardo Nevola, Barbara Guerrera, Natalina Iuliano, Michele Imparato, Alessio Trabucco, Ferdinando Carlo Sasso, Filomena Morisco, Antonio Ascione, Guido Piai, Luigi Elio Adinolfi. Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life ExperienceDigestive Diseases and Sciences 2019; 64(10): 3013 doi: 10.1007/s10620-019-05604-8
14
Alper Sonmez, Cemal Nuri Ercin, Mustafa Cesur, Teoman Dogru. Nutraceuticals and Cardiovascular DiseaseContemporary Cardiology 2021; : 141 doi: 10.1007/978-3-030-62632-7_9
15
Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo. Extra-hepatic manifestations and complications of nonalcoholic fatty liver diseaseFuture Medicinal Chemistry 2019; 11(16): 2171 doi: 10.4155/fmc-2019-0003
16
Luca Rinaldi, Veronica Folliero, Luciana Palomba, Carla Zannella, Rachele Isticato, Raffaele Di Francia, Massimiliano Berretta, Ilario de Sio, Luigi E. Adinolfi, Giancarlo Morelli, Secondo Lastoria, Lucia Altucci, Carlo Pedone, Massimiliano Galdiero, Gianluigi Franci. Sonoporation by microbubbles as gene therapy approach against liver cancerOncotarget 2018; 9(63): 32182 doi: 10.18632/oncotarget.25875
17
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLDInternational Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
18
N. A. Cherkashchenko, M. A. Livzan, T. S. Krolevets. Features of the course of gallstone disease in patients with non-alcoholic fatty liver diseaseTerapevticheskii arkhiv 2020; 92(2): 48 doi: 10.26442/00403660.2020.02.000550
19
Amedeo Lonardo. Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?Journal of Clinical Medicine 2021; 10(3): 492 doi: 10.3390/jcm10030492
20
Muraly Puttabyatappa, Jacob D. Martin, Victoria Andriessen, Micaela Stevenson, Lixia Zeng, Subramaniam Pennathur, Vasantha Padmanabhan. Developmental programming: Changes in mediators of insulin sensitivity in prenatal bisphenol A-treated female sheepReproductive Toxicology 2019; 85: 110 doi: 10.1016/j.reprotox.2019.03.002
21
Sheila Maier, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan, Miguel A. Lanaspa, Richard J. Johnson, Thomas Jensen. Lean NAFLD: an underrecognized and challenging disorder in medicineReviews in Endocrine and Metabolic Disorders 2021; 22(2): 351 doi: 10.1007/s11154-020-09621-1
22
Pegah Golabi, James Paik, Rashmi Reddy, Elisabetta Bugianesi, Gregory Trimble, Zobair M. Younossi. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United StatesBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0972-6
23
Tatiana R. Romantsova, Yulia P. Sych. Immunometabolism and metainflammation in obesityObesity and metabolism 2019; 16(4): 3 doi: 10.14341/omet12218
24
Jonathan G. Stine, Christopher Soriano, Ian Schreibman, Gloriany Rivas, Breianna Hummer, Esther Yoo, Kathryn Schmitz, Christopher Sciamanna. Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences 2020;  doi: 10.1007/s10620-020-06673-w
25
Nicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, Sonja M. Kessler, Julia Unterluggauer, Stefanie Krassnig, Kensuke Kojima, Xintong Chen, Yujin Hoshida, Nabeel M. Bardeesy, Heimo Müller, Vendula Svendova, Michael G. Schimek, Clemens Diwoky, Alexandra Lipfert, Vineet Mahajan, Cornelia Stumptner, Andrea Thüringer, Leopold F. Fröhlich, Tatjana Stojakovic, K.P.R. Nilsson, Thomas Kolbe, Thomas Rülicke, Thomas M. Magin, Pavel Strnad, Alexandra K. Kiemer, Richard Moriggl, Johannes Haybaeck. High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer PhenotypeTranslational Oncology 2019; 12(2): 256 doi: 10.1016/j.tranon.2018.10.010
26
Simonetta Lugari, Alessandro Mantovani, Fabio Nascimbeni, Amedeo Lonardo. Hypothyroidism and nonalcoholic fatty liver disease – a chance association?Hormone Molecular Biology and Clinical Investigation 2018; 0(0) doi: 10.1515/hmbci-2018-0047
27
Yang Zhang, Jun-Xiang Li, Yan Zhang, Yun-Liang Wang. Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis World Journal of Clinical Cases 2021; 9(23): 6654-6662 doi: 10.12998/wjcc.v9.i23.6654
28
Jaime Ruiz-Tovar, Lorea Zubiaga. Validation of biochemical scores for liver steatosis before and 1 year after sleeve gastrectomySurgery for Obesity and Related Diseases 2019; 15(9): 1447 doi: 10.1016/j.soard.2019.05.004
29
Amedeo Lonardo, Stefano Ballestri. Perspectives of nonalcoholic fatty liver disease research: a personal point of viewExploration of Medicine 2020; 1(3): 85 doi: 10.37349/emed.2020.00007
30
Yao Zhang, Kongdong Li, Anqi Kong, Yang Zhou, Dongfeng Chen, Jie Gu, Haifeng Shi. Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutantsEcotoxicology and Environmental Safety 2021; 217: 112256 doi: 10.1016/j.ecoenv.2021.112256
31
Fan Zheng, Ying Cai. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat dietLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-018-0933-z
32
Sergey GUSHCHA, Natalia DRAGOMIRETSKA, Iryna ZABOLOTNA, Boris NASIBULLIN, Anna IZHA, Natalia ВADIUK, Khrystyna KOIEVA, Constantin MUNTEANU. Possibilities of using natural mineral waters in the treatment of patients with non-alcoholic fatty liver diseaseBalneo Research Journal 2019; 10(Vol 10 No. 4): 450 doi: 10.12680/balneo.2019.280
33
Meng Zhang, Li Li, Jing Chen, Bei Li, Yutao Zhan, Chuan Zhang. Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver diseaseMedicine 2019; 98(18): e15362 doi: 10.1097/MD.0000000000015362
34
Ahad Eshraghian, Saman Nikeghbalian, Bita Geramizadeh, Kourosh Kazemi, Alireza Shamsaeefar, Seyed Ali Malek-Hosseini. Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acidClinics and Research in Hepatology and Gastroenterology 2020; 44(4): 572 doi: 10.1016/j.clinre.2019.09.002
35
Amedeo Lonardo, Ayako Suzuki. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational ResearchJournal of Clinical Medicine 2020; 9(5): 1278 doi: 10.3390/jcm9051278
36
Guilherme Moura Cunha, Patrick J Navin, Kathryn J Fowler, Sudhakar K Venkatesh, Richard L Ehman, Claude B Sirlin. Quantitative magnetic resonance imaging for chronic liver diseaseThe British Journal of Radiology 2021; 94(1121): 20201377 doi: 10.1259/bjr.20201377
37
Niki Katsiki, Michael Doumas, Vasilios Athyros. Metabolic syndrome: joint diagnostic criteria and links with comorbiditiesHormones 2019; 18(1): 107 doi: 10.1007/s42000-018-0074-9
38
Carlo Acierno, Alfredo Caturano, Pia Clara Pafundi, Riccardo Nevola, Luigi Elio Adinolfi, Ferdinando Carlo Sasso. Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coinExploration of Medicine 2020; 1(5) doi: 10.37349/emed.2020.00019
39
Virginia Esteve-Luque, Ariadna Padró-Miquel, Marta Fanlo-Maresma, Emili Corbella, Xavier Corbella, Xavier Pintó, Beatriz Candás-Estébanez. Implication between Genetic Variants from APOA5 and ZPR1 and NAFLD Severity in Patients with HypertriglyceridemiaNutrients 2021; 13(2): 552 doi: 10.3390/nu13020552
40
Qian Chen, Mengyang Liu, Haiyang Yu, Jian Li, Sijian Wang, Yi Zhang, Feng Qiu, Tao Wang. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathwayJournal of Natural Medicines 2018; 72(3): 655 doi: 10.1007/s11418-018-1199-5
41
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, Alberto Mondelli, Serena Bursi, Giovanna Onfiani, Francesca Carubbi, Amedeo Lonardo. Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foesAtherosclerosis 2019; 284: 66 doi: 10.1016/j.atherosclerosis.2019.02.028
42
Yunxiao Gao, Rongrong Tian, Haiyue Liu, Huimin Xue, Ruizhe Zhang, Suping Han, Lin Ji, Weidong Huang, Jicheng Zhan, Yilin You. Research progress on intervention effect and mechanism of protocatechuic acid on nonalcoholic fatty liver diseaseCritical Reviews in Food Science and Nutrition 2021; : 1 doi: 10.1080/10408398.2021.1939265
43
Cene Skubic, Živa Drakulić, Damjana Rozman. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugsExpert Opinion on Drug Metabolism & Toxicology 2018; 14(8): 831 doi: 10.1080/17425255.2018.1492552
44
Teodora Barbalata, Mariana Deleanu, Mihaela Georgiana Carnuta, Loredan Stefan Niculescu, Mina Raileanu, Anca Volumnia Sima, Camelia Sorina Stancu. Hyperlipidemia Determines Dysfunctional HDL Production and Impedes Cholesterol Efflux in the Small Intestine: Alleviation by Ginger ExtractMolecular Nutrition & Food Research 2019; 63(19): 1900029 doi: 10.1002/mnfr.201900029
45
Yuanyuan Meng, Yong Liu, Ningning Fang, Yongmin Guo. Hepatoprotective effects of Cassia semen ethanol extract on non-alcoholic fatty liver disease in experimental ratPharmaceutical Biology 2019; 57(1): 98 doi: 10.1080/13880209.2019.1568509
46
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Maria Vittoria Morone, Chiara Silvestri, Mauro Giordano, Teresa Salvatore, Ferdinando Carlo Sasso. Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative ReviewAntioxidants 2021; 10(2): 270 doi: 10.3390/antiox10020270
47
Zobair M. Younossi, Maria Stepanova, Janus Ong, Greg Trimble, Saleh AlQahtani, Issah Younossi, Aijaz Ahmed, Andrei Racila, Linda Henry. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United StatesClinical Gastroenterology and Hepatology 2021; 19(3): 580 doi: 10.1016/j.cgh.2020.05.064
48
Simona Cernea, Itamar Raz. NAFLD in type 2 diabetes mellitus: Still many challenging questions Diabetes/Metabolism Research and Reviews 2021; 37(2) doi: 10.1002/dmrr.3386
49
Preya Janubhai Patel, Fabrina Hossain, Leigh Ula Horsfall, Xuan Banh, Kelly Lee Hayward, Suzanne Williams, Tracey Johnson, Nigel Neil Brown, Nivene Saad, Patricia Casarolli Valery, Katharine Margaret Irvine, Andrew Donald Clouston, Katherine Anne Stuart, Anthony William Russell, Elizabeth Ellen Powell. Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic controlJournal of Diabetes and its Complications 2018; 32(8): 799 doi: 10.1016/j.jdiacomp.2018.05.008
50
Tomislav Kizivat, Ivana Maric, Dunja Mudri, Ines Bilic Curcic, Dragan Primorac, Martina Smolic. Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic ImplicationsJournal of Clinical and Translational Hepatology 2020; 8(3): 1 doi: 10.14218/JCTH.2020.00027
51
Stefano Bellentani, Giorgio Bedogni, Claudio Tiribelli. Two drinks per day does not take your fatty liver awayHepatology 2018; 67(6): 2072 doi: 10.1002/hep.29753
52
Faisal M Sanai, Faisal Abaalkhail, Fuad Hasan, Muhammad Hamed Farooqi, Nawal Al Nahdi, Zobair M Younossi. Management of nonalcoholic fatty liver disease in the Middle EastWorld Journal of Gastroenterology 2020; 26(25): 3528-3541 doi: 10.3748/wjg.v26.i25.3528
53
Guohong Qin, Ji Ma, Qiongshan Huang, Hongli Yin, Jichun Han, Maoru Li, Yang Deng, Bing Wang, Waseem Hassan, Jing Shang. Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat ModelInternational Journal of Molecular Sciences 2018; 19(12): 4126 doi: 10.3390/ijms19124126
54
Si-Qin Long, Xiu-Feng Yu, Yu-Li Ge, Lu-Xiang Liu. Ginkgolide B ameliorates high-fat diet-induced hepatic steatosis and inflammation in miceWorld Chinese Journal of Digestology 2020; 28(13): 519 doi: 10.11569/wcjd.v28.i13.519
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
55
Rishi Rikhi, Tavankit Singh, Jamak Modaresi Esfeh. Work up of fatty liver by primary care physicians, reviewAnnals of Medicine and Surgery 2020; 50: 41 doi: 10.1016/j.amsu.2020.01.001
56
Shufei Zang, Jin Chen, Yu Song, Lang Bai, Jinjun Chen, Xiaoling Chi, Fangping He, Huiping Sheng, Jing Wang, Shilong Xie, Wen Xie, Yongfeng Yang, Jing Zhang, Minghua Zheng, Zhengsheng Zou, Bingyuan Wang, Junping Shi. Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial DesignAdvances in Therapy 2018; 35(2): 218 doi: 10.1007/s12325-018-0670-8
57
Rourke D. Decker, Eric M. Ghiraldi, Alexandra H. Weiss, John P. Gaughan, Justin I. Friedlander. Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Nephrolithiasis in Women: Findings from NHANES IIIJournal of Endourology 2020; 34(12): 1258 doi: 10.1089/end.2020.0486
58
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An OverviewInternational Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
59
Madan Kumar Arumugam, Matthew C. Paal, Terrence M. Donohue, Murali Ganesan, Natalia A. Osna, Kusum K. Kharbanda. Beneficial Effects of Betaine: A Comprehensive ReviewBiology 2021; 10(6): 456 doi: 10.3390/biology10060456
60
Priyankar Dey, Bryan D. Olmstead, Geoffrey Y. Sasaki, Yael Vodovotz, Zhongtang Yu, Richard S. Bruno. Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiotaThe Journal of Nutritional Biochemistry 2020; 84: 108455 doi: 10.1016/j.jnutbio.2020.108455
61
Anita Morandi, Anna Di Sessa, Chiara Zusi, Giuseppina Rosaria Umano, Dania El Mazloum, Elena Fornari, Emanuele Miraglia del Giudice, Giovanni Targher, Claudio Maffeis. Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization AnalysisThe Journal of Clinical Endocrinology & Metabolism 2020; 105(11) doi: 10.1210/clinem/dgaa583
62
Katsumi Iizuka. Dietary Interventions in Liver Disease2019; : 263 doi: 10.1016/B978-0-12-814466-4.00022-7
63
Flavio A. Cadegiani. Dietary Interventions in Liver Disease2019; : 39 doi: 10.1016/B978-0-12-814466-4.00004-5
64
Hayat Mohamed Suliman, Bashier Osman, Iman H. Abdoon, Amir Mustafa Saad, Hassan Khalid. Ameliorative activity of Adansonia digitata fruit on high sugar/high fat diet-simulated Metabolic Syndrome model in male Wistar ratsBiomedicine & Pharmacotherapy 2020; 125: 109968 doi: 10.1016/j.biopha.2020.109968
65
Manu V. Chakravarthy, Brent A. Neuschwander‐Tetri. The metabolic basis of nonalcoholic steatohepatitisEndocrinology, Diabetes & Metabolism 2020; 3(4) doi: 10.1002/edm2.112
66
Tomoe Kinoshita, Masashi Shimoda, Koji Nakashima, Yoshiro Fushimi, Yurie Hirata, Akihito Tanabe, Fuminori Tatsumi, Hidenori Hirukawa, Junpei Sanada, Kenji Kohara, Shintaro Irie, Tomohiko Kimura, Yoshiko Nakamura, Momoyo Nishioka, Atsushi Obata, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto. Comparison of the effects of three kinds of glucose‐lowering drugs on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open‐label, three‐arm, active control studyJournal of Diabetes Investigation 2020; 11(6): 1612 doi: 10.1111/jdi.13279
67
Mattia Bellan, Cosimo Colletta, Matteo Nazzareno Barbaglia, Livia Salmi, Roberto Clerici, Venkata Ramana Mallela, Luigi Mario Castello, Giuseppe Saglietti, Gian Piero Carnevale Schianca, Rosalba Minisini, Mario Pirisi. Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 PolymorphismsDiabetes & Metabolism Journal 2019; 43(5): 700 doi: 10.4093/dmj.2018.0201
68
Shou-Sheng Liu, Xue-Feng Ma, Jie Zhao, Shui-Xian Du, Jie Zhang, Meng-Zhen Dong, Yong-Ning Xin. Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysisLipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01288-6
69
T. Karlas. Diagnose und Verlaufsbeurteilung von FettlebererkrankungenDer Gastroenterologe 2018; 13(4): 272 doi: 10.1007/s11377-018-0263-8
70
Daniel G Tenen, Li Chai, Justin L Tan. Metabolic alterations and vulnerabilities in hepatocellular carcinomaGastroenterology Report 2021; 9(1): 1 doi: 10.1093/gastro/goaa066
71
Ling-Yan Yu, Wei-Ying Li, Jia Lin. Juglanin improves lipid metabolism disorder, liver injury, and intestinal integrity in nonalcoholic fatty liver miceWorld Chinese Journal of Digestology 2020; 28(4): 113 doi: 10.11569/wcjd.v28.i4.113
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
72
AshrafG Dala, El-ArabA. A. Ezz, AhmedK. Abd Elaziz Ewida. The relationship between nonalcoholic fatty liver disease and cancersMenoufia Medical Journal 2021; 34(2): 409 doi: 10.4103/mmj.mmj_312_19
73
Jingjing Cai, Xiao-Jing Zhang, Hongliang Li. Progress and challenges in the prevention and control of nonalcoholic fatty liver diseaseMedicinal Research Reviews 2019; 39(1): 328 doi: 10.1002/med.21515
74
Mina Movahedian, Jamal Rahmani, Seyed Saeed Hashemi Nazari, Susan Mohamadi, Gurudatta Naik, Azita Hekmatdoost. Fatty liver index and risk of diabetes incidence: A systematic review and dose-response meta-analysis of cohort studiesPrimary Care Diabetes 2020; 14(6): 577 doi: 10.1016/j.pcd.2020.02.011
75
David Romero‐Pérez, Isabel Belinchón‐Romero, Pablo Bellot, Rubén Francés, Francisco Marco, Jose Manuel Ramos‐Rincón. Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular riskAustralasian Journal of Dermatology 2019; 60(4) doi: 10.1111/ajd.13098
76
Chiao-Lin Hsu, Fu-Zong Wu, Kung-Hung Lin, Yu-Hsun Chen, Pin-Chieh Wu, Yan-Hua Chen, Chi-Shen Chen, Wen-Hwa Wang, Guang-Yuan Mar, Hsien-Chung Yu. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health CheckupClinical and Translational Gastroenterology 2019; 10(5): e00042 doi: 10.14309/ctg.0000000000000042
77
Elena-Daniela Grigorescu, Mariana Floria, Cristina Mihaela Lăcătușu, Bogdan Mircea-Mihai, Ioana Creţu, Alina Delia Popa, Alina Onofriescu, Irina M. Jaba, Victoriţa Șorodoc, Alexandr Ceasovschih, Laurenţiu Șorodoc. The Relationship between Hepatic Steatosis, inflammation and insulin Resistance in type 2 Diabetes with Metabolic ImbalanceInternal Medicine 2019; 16(4): 13 doi: 10.2478/inmed-2019-0073
78
Liu Li, Li Yang, Feng Yang, Xin-lan Zhao, Shengjiang Xue, Fang-hua Gong. Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed MiceJournal of Inflammation Research 2021; : 1959 doi: 10.2147/JIR.S302934
79
Zhibo Zhao, Li Zhong, Peizhi Li, Kun He, Chan Qiu, Lei Zhao, Jianping Gong. Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5pExperimental Cell Research 2020; 387(1): 111738 doi: 10.1016/j.yexcr.2019.111738